I am starting to now believe - rather than hope, that all 4 of the current phase 2 trials will be successful.
Similar ailments treated by the same drug.
Efficacy is the only real variant.
And then phase 3 - with this science? With this management team - I believe they will be successul too (albeit with the fact that Neuren themselves have not as yet got a drug past phase 3).
They must have learnt something with Trofinetide regarding that! And they have plenty of cash to hire/contract the right people to do the job.
- Forums
- ASX - By Stock
- NEU
- Ann: Completion of enrolment in Neuren's Angelman P2 trial
Ann: Completion of enrolment in Neuren's Angelman P2 trial, page-7
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$14.07 |
Change
-0.400(2.76%) |
Mkt cap ! $1.827B |
Open | High | Low | Value | Volume |
$14.47 | $14.53 | $13.99 | $6.131M | 431.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 794 | $14.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 86 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 1026 | 14.060 |
11 | 783 | 14.050 |
12 | 1062 | 14.040 |
5 | 631 | 14.030 |
5 | 606 | 14.020 |
Price($) | Vol. | No. |
---|---|---|
14.070 | 205 | 10 |
14.080 | 663 | 8 |
14.090 | 640 | 4 |
14.100 | 1070 | 5 |
14.110 | 722 | 4 |
Last trade - 15.58pm 03/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |